Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The EurasiaBio Congress is the flagship international event of the Eurasian Technology Platform 'EurasiaBIO' (ETP EurasiaBio), a strategic consortium focused on the development of biotechnology and the bioeconomy within the Eurasian Economic Union (EAEU). Coordinated by the Russian Biotechnology Society, the platform facilitates collaboration between industry, academia, and government across Russia, Belarus, Kazakhstan, and Armenia to advance research and technology transfer. Its primary focus areas include biopharmaceuticals, bioenergy, agricultural biotechnology, and industrial biorefining. The platform aims to create a unified bioeconomic space by supporting the commercialization of innovative technologies, developing industry standards, and organizing major networking forums like the EurasiaBio Congress. It plays a central role in the regional implementation of biotechnology strategies and international scientific cooperation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EurasiaBio Congress.